BMJ: Clinical trial data for all drugs in current use must be available for independent scrutiny
In an impassioned editorial, BMJ editor Fiona Godlee calls on the pharmaceutical industry to release clinical trial data on all approved drugs, and on medical journals to publish industry-funded trials only when there is a commitment to make patient-level data available on reasonable request. She states that the BMJ will require this commitment for all clinical trials of drugs and devices, whether industry-funded or not, beginning in January 2013. In addition, BMJ is publishing online all correspondence between Roche and the Cochrane Collaboration researchers regarding the oseltamivir (Tamiflu) data. More on the battle for Tamiflu data here.
Addendum 11/2/2012: read Pharmalot’s coverage here.
Posted on October 29, 2012, in data sharing, drug safety, medical device safety, scholarly journals and tagged BMJ, Cochrane Collaboration, data sharing, Fiona Godlee, open science, oseltamivir, Peter Doshi, Roche, Tamiflu, Tom Jefferson. Bookmark the permalink. Leave a comment.